Byline: Will Doss
-
Mechanism Behind Common Parkinson’s Mutation Discovered
Northwestern Medicine scientists uncovered the molecular process behind a buildup of toxic proteins in Parkinson’s patients, a discovery that may lead to improved therapies.
-
Feinberg Commemorates Martin Luther King Jr. With a Week of Discussion and Awareness
Feinberg capped off its week-long celebration of Martin Luther King Jr. with a keynote address by Charles Blow, op-ed columnist at the New York Times, political commentator on CNN and former Presidential Visiting Professor at Yale University.
-
Genetic Basis Uncovered for Glaucoma
Northwestern Medicine scientists have discovered mutations that cause improper drainage and a buildup of ocular pressure leading to glaucoma, suggesting a path towards future treatments.
-
Feinberg Awarded Fourth AHA Research Center
A newly announced American Heart Association research center will be led by Mary McDermott, MD, and focus on calf muscle pathology in peripheral artery disease.
-
Untangling How Epstein-Barr Virus Infects Cells
Northwestern Medicine scientists have discovered a protein that acts as an entry point for the Epstein-Barr virus, providing a potential target for future therapies.
-
Tracking Protein Disposal Could Lead to Improved Therapies
A new Northwestern Medicine study detailed a technique that could help scientists find the cause of cancer or autism-spectrum disease stemming from faulty protein disposal.
-
Exploring Techniques for Bedside Diagnostic Reasoning
Georges Bordage, MD, MSc, PhD, professor of Medical Education at the University of Illinois at Chicago, delivered a talk on diagnostic reasoning and how to teach it to trainees.
-
Breaking Ground in the Field of Personalized Neurology
A team from the academic and clinical arms of Northwestern Medicine has been assembled to study patient DNA and create customized therapies for Parkinson’s, Epilepsy, and ALS in a model called Personalized Neurology.
-
Molecular Mechanism Behind HIV-Associated Dementia Revealed
Northwestern Medicine scientists showed how enzyme inhibitors might be used to halt a molecular process that can cause neurodegeneration in patients with HIV.
-
Scientists Reprogram Stem Cells to Regenerate Muscle in Muscular Dystrophy
Scientists are one step closer to a stem cell treatment for muscular dystrophy after Northwestern Medicine investigators demonstrated improvements in muscle tissue differentiation in stem cells.
